qz
FDA picks Eli Lilly and Regeneron for program to speed up domestic drug factory reviews

The FDA estimates the PreCheck program could save participating companies up to 14 months by reviewing facilities while they are still under construction [...]

Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
23andMe bought by Regeneron in court auction

It has been nearly two months since 23andMe declared bankruptcy and the company has officially been sold. The US biotech company Regeneron has agreed to buy 23andMe and all of its assets for $256 mill [...]

Match Score: 128.57

Destination
Eli Lilly signs $2.75 billion deal with AI drug developer Insilico Medicine

US pharmaceutical giant Eli Lilly is betting big on AI-driven drug development, signing a $2.75 billion deal with Hong Kong-listed Insilico Medicine.<br /> The article Eli Lilly signs $2.75 bill [...]

Match Score: 87.38

venturebeat
Most companies think they're building a software factory. They're actually just shipping bugs faster.

Industrialized factories changed how the world produced physical goods: more output, lower costs, faster than anything that came before. Now a similar shift is happening with software. LLMs have lowe [...]

Match Score: 86.56

Destination
The FDA rolls out its own AI to speed up clinical reviews and scientific evaluations

The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinforma [...]

Match Score: 86.43

Destination
Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s drug came out on top.Read more... [...]

Match Score: 83.84

Destination
23andMe founder Anne Wojcicki will regain control of embattled DNA company after all

In a surprise twist, 23andMe founder and former CEO Anne Wojcicki is set to regain control of the DNA company's assets, according to a press release from 23andMe. In May, a company called Regener [...]

Match Score: 81.55

Destination
Eli Lilly's online health platform just expanded beyond weight loss to tackle Alzheimer’s

Just about a year after launching a direct-to-consumer online platform to sell treatments for diabetes and obesity, Eli Lilly (LLY) is now expanding the program to offer resources for Alzheimer’s d [...]

Match Score: 70.03

Destination
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup

An Eli Lilly exec said the company’s experimental weight-loss pill could make GLP-1 treatments more accessible worldwide, as it would be easier to manufacture and distribute globally. Three U.S. sen [...]

Match Score: 68.30

Destination
The best Prime Day TV deals still available on day 2: Take up to $500 off sets from Samsung, LG, Sony and more

While Black Friday remains the best time to grab a new TV at a discount, Amazon’s latest October Prime Day sale is a decent opportunity to take the plunge if you need to upgrade right away. We' [...]

Match Score: 65.78